It was shown to reduce S1P levels and SK1 and S1PR1 expression in the breast tumors, as well as reduce key proinflammatory cytokines, macrophage infiltration, and tumor progression induced by obesity (120). Here, SPHK1 is linked to obesity due to melanocortin 4 receptor deficiency.